Oral Liquid Potassium Chloride Dosing Pathway in a Tertiary Care Veteran Affairs Academic Medical Center
- PMID: 31478945
- DOI: 10.1097/HPC.0000000000000197
Oral Liquid Potassium Chloride Dosing Pathway in a Tertiary Care Veteran Affairs Academic Medical Center
Abstract
Hypokalemia, defined as a serum potassium (K) concentration of <3.5 mEq/L, is an electrolyte imbalance commonly found in hospitalized patients. Hypokalemia is associated with potentially severe complications, including arrhythmias, which necessitate careful monitoring and repletion with potassium. In the inpatient setting, serum K may be repleted via intravenous or oral routes, with oral administration preferred. Potassium chloride (KCl) for oral administration is widely available in both immediate as well as an extended release formulations. Immediate release liquid KCl is optimal for inpatient use since it demonstrates rapid absorption and subsequent increase in serum K levels. However, acquisition costs for unit dose oral liquid KCl have prompted some institutions to implement guidance for appropriate use of KCl oral liquid. In this article, we describe the creation of a clinical pathway for ordering of oral immediate release KCl for inpatients at a tertiary Veterans Affairs Academic Medical Center.
Similar articles
-
Potassium Chloride Sustained Release Dosing Pathway in an Academic Medical Center.Crit Pathw Cardiol. 2017 Dec;16(4):158-160. doi: 10.1097/HPC.0000000000000134. Crit Pathw Cardiol. 2017. PMID: 29135624
-
Safety, Efficacy, and Timeliness of Intravenous Potassium Chloride Replacement Protocols in a Pediatric Cardiothoracic Intensive Care Unit.J Intensive Care Med. 2020 Apr;35(4):371-377. doi: 10.1177/0885066617752659. Epub 2018 Jan 22. J Intensive Care Med. 2020. PMID: 29357785
-
Efficacy of oral potassium chloride administration in treating lactating dairy cows with experimentally induced hypokalemia, hypochloremia, and alkalemia.J Dairy Sci. 2014 Mar;97(3):1413-26. doi: 10.3168/jds.2013-6982. Epub 2013 Dec 28. J Dairy Sci. 2014. PMID: 24377802 Clinical Trial.
-
Therapeutic approach to hypokalemia.Nephron. 2002;92 Suppl 1:28-32. doi: 10.1159/000065374. Nephron. 2002. PMID: 12401935 Review.
-
Oral potassium supplementation in surgical patients.Int J Surg. 2008 Aug;6(4):287-8. doi: 10.1016/j.ijsu.2008.03.007. Epub 2008 Mar 28. Int J Surg. 2008. PMID: 18485847 Review.
References
-
- Stone MS, Martyn L, Weaver CM. Potassium intake, bioavailability, hypertension, and glucose control. Nutrients. 2016; 8:E444.
-
- National Institutes of Health. Potassium Fact Sheet for Health Professionals. Available at: https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/. Accessed July 17, 2019.
-
- Kovesdy CP, Appel LJ, Grams ME, et al. Potassium homeostasis in health and disease: a scientific workshop cosponsored by the national kidney foundation and the American Society of Hypertension. J Am Soc Hypertens. 2017;11:783–800.
-
- Gumz ML, Rabinowitz L, Wingo CS. An integrated view of potassium homeostasis. N Engl J Med. 2015;373:60–72.
-
- Cohn JN, Kowey PR, Whelton PK, et al. New guidelines for potassium replacement in clinical practice: a contemporary review by the national council on potassium in clinical practice. Arch Intern Med. 2000;160:2429–2436.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources